• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Greenovation Biotech - Articles and news items

Greenovation to start Phase I clinical trial for moss-aGal

Industry news / 16 September 2015 / Victoria White

Moss-aGal, a recombinant form of human alpha galactosidase, is the world´s first moss-produced drug candidate…


Webinar: SIFT-MS: A New Tool for Impurity Profiling in Pharmaceutical ProductsLEARN MORE
+ +